Intercontinental Exchange enters September on the back foot — down 1.3% on the week to $159.60 — yet the analyst community is more constructive than the price action suggests, creating a gap worth examining.
The Street's posture on ICE is firmly positive despite the recent drift. After Q2 results in late July, UBS raised its target to $195 (from $190), TD Cowen lifted to $177 (from $159), and Barclays nudged to $182 (from $180) — all maintaining Buy or Overweight ratings. The consensus mean price target of $186.64 implies roughly 17% upside from current levels. That constructive tilt is captured in the factor scores: analyst recommendation differential ranks in the 95th percentile, meaning the Street is more bullish on ICE relative to the broader universe than on almost any other name. EPS momentum over the last 30 days ranks at 62 — decent, though the 90-day reading slips to 35, reflecting some near-term estimate volatility. The bull case rests on strong derivatives volumes and the ongoing Black Knight integration expanding ICE's presence in mortgage technology. Bears point to sensitivity to volume cycles and regulatory headwinds in the US and UK.
The options market is telling a notably different story from the cautious price action. The put/call ratio has dropped to 0.37, well below its 20-day average of 0.40 and roughly 1.3 standard deviations beneath that mean — meaning options traders are actually tilting toward calls, not puts. The PCR sits near its 52-week low of 0.28, a range that reflects investor appetite for upside exposure rather than defensive hedging. That call-skewed positioning is at odds with the mild selloff and suggests at least some participants view the dip as an opportunity rather than a warning sign.
Short interest adds almost nothing to the narrative here — and that's the point. Bears hold just 1.3% of the free float, a figure that has fallen roughly 16% over the past month as the position wound down from around 9 million shares in early August to 7.7 million now. Borrowing costs are negligible at 0.44%, and availability is essentially unlimited, with over 559 million shares available to borrow against a borrowed position of barely 7.6 million. There is no short-side pressure in this stock. The ORTEX short score of 29 confirms the same: ICE ranks in the lower third of the universe on bearish positioning metrics.
On the ownership side, the institutional register is stable and index-heavy. BlackRock and Vanguard together account for over 16% of shares. Millennium Management added 3.7 million shares in the quarter through June — a meaningful move for a fund of that profile — though the data covers the period to June 30. Recent insider activity is routine and carries no real signal: a director and the General Counsel each sold modest amounts in late August, all under pre-arranged 10b5-1 plans.
The next earnings date is October 29. The last two quarterly prints saw muted reactions — a 0.3% gain after August's release and a 1.2% decline after the prior quarter. With ICE trading at a P/E of 18.8x and EV/EBITDA near 14.4x — multiples that have risen modestly over the past month — and the stock sitting roughly 17% below the analyst consensus target, the setup heading into Q3 results is less about whether bears are pressing and more about whether the analyst community's optimism can find a price catalyst to close that gap.
See the live data behind this article on ORTEX.
Open ICE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
